Skip to content
DataLookout
Menu

NCT06322888

Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 30, 2026 to Sep 30, 2027 Show 5 more changesShow less
    • Eligibility criteria expanded, about 13 words
    • Enrollment closed, study ongoing
    • Study completion pushed from Dec 31, 2026 to Dec 31, 2027
    • Secondary endpoints: details revised at 11 of 14 entries
    • Site details revised at 2 of 2 sites
  2. Notable Primary completion date: Sep 30, 2025 to Sep 30, 2026
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2024 to Mar 28, 2024
    • Site details revised at 2 of 2 sites
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in Irisin in Exercise Group
Timeframe: At baseline, within 2 hours of 1st exercise session, and at week 12, up to 16 weeks
Change in Irisin in Control Group
Timeframe: At baseline and week 12, up to 16 weeks

Secondary (14)

Change in Tissue Markers in Exercise Group
Change in Tissue Markers in Control Group
Change in Biomarkers in Exercise Group - Meso scale
Change in Biomarkers in Exercise Group - Mass cytometry
Change in Biomarkers in Control Group - Meso Scale
Show 9 moreShow less
Change in Biomarkers in Control Group - Mass cytometry
Change in Participant Weight in Exercise Group
Change in Participant Weight in Control Group
Change in Cardiorespiratory Fitness in Exercise Group
Change in Cardiorespiratory Fitness in Control Group
10-Repetition Max Test in Exercise Group
10-Repetition Max Test in Control Group
Change in Minutes of Total Exercise for Exercise Group
Change in Minutes of Total Exercise for Control Group

Arms and interventions

Arm A: Exercise InterventionExperimental

Participants will be randomized and will complete: * Baseline study visit with assessments, breast biopsy, and blood draw. * Exercise program for 12 weeks 3x weekly and exercise logs. Additional blood draw after first exercise session. * End of study visit with assessments, breast biopsy, and blood draw.

Arm B: Waitlist ControlNo intervention

Participants will be randomized and will complete: * Baseline study visit with assessments, breast biopsy, and blood draw. * End of study visit with assessments, breast biopsy, and blood draw. * Participants will be offered a complimentary 12-week exercise program after completing the study.

Behavioral: Exercise Training Program

Sites

2 sites in 1 country